Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time.
Nathalie Damon-Perrière, Alexandra Foubert-Samier, Valérie Cochen De Cock...
https://pubmed.ncbi.nlm.nih.gov/22236582/Actively Recruiting
Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-04-17
100
Participants Needed
2
Research Sites
13 weeks
Total Duration
Researchers are studying patients with amyotrophic lateral sclerosis ALS within 18 months of their first motor symptoms to understand how the autonomic and sensory nervous systems change as the disease progresses. The study aims to find out if early autonomic dysfunction relates to disease progression and survival, and whether skin biomarkers can help track the disease and evaluate future treatments. Healthy people matched by age and sex will be included for comparison. Participants include ALS patients and healthy controls. ALS patients will undergo clinical exams, questionnaires on symptoms, quality of life, pain, and neuropsychological tests. They will also have genetic screening and tests of the autonomic nervous system, including skin biopsies and cardiovascular reflex testing. Follow-up assessments, including skin biopsies and clinical scales, will be done about six months later to monitor changes. During the study, researchers will collect blood samples, conduct skin biopsies to study nerve fibers, and perform cardiovascular and sweat function tests. Questionnaires and clinical scales will help evaluate symptoms and quality of life. The main outcomes measured are the sensory and autonomic nerve innervation at recruitment and follow-up. This study will last until December 2026 and includes ongoing monitoring of participants disease progression and nervous system involvement.
CONDITIONS
Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS
M
Maria Nolano, MD, PhD
G
Giuseppe Caporaso
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At recruitment and at follow-up approximately 6 months later
Participants undergo diagnostic tests including skin biopsy, cardiovascular reflexes testing, clinical scales evaluating autonomic and sensory symptoms, and dynamic sweat test to assess autonomic and sensory nervous system function.
2 visits (in-person): 1 at recruitment and 1 follow-up around 6 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Nathalie Damon-Perrière, Alexandra Foubert-Samier, Valérie Cochen De Cock...
https://pubmed.ncbi.nlm.nih.gov/22236582/M Nolano, V Provitera, F Manganelli...
https://pubmed.ncbi.nlm.nih.gov/27288647/Mamede deCarvalho, Marta Gromicho, Peter Andersen...
https://pubmed.ncbi.nlm.nih.gov/33372053/Adriano Chiò, Gabriele Mora, Giuseppe Lauria
https://pubmed.ncbi.nlm.nih.gov/27964824/Colin J Mahoney, Rebekah M Ahmed, William Huynh...
https://pubmed.ncbi.nlm.nih.gov/33993457/B R Brooks, R G Miller, M Swash...
https://pubmed.ncbi.nlm.nih.gov/11464847/Alessandra Fasolino, Giulia Di Stefano, Caterina Leone...
https://pubmed.ncbi.nlm.nih.gov/32897040/J Weis, I Katona, G Müller-Newen...
https://pubmed.ncbi.nlm.nih.gov/21646630/Francesco Gentile, Stefania Scarlino, Yuri Matteo Falzone...
https://pubmed.ncbi.nlm.nih.gov/31293369/Nanna B Finnerup, Simon Haroutounian, Peter Kamerman...
https://pubmed.ncbi.nlm.nih.gov/27115670/Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor